Latest Optimata Ltd. Stories
Optimata Ltd., developer of the proprietary Optimata Virtual Patient(R) technology to navigate drug development, announced today that a scientific paper based on research carried out by company scientists will be published in the prestigious "Cancer Research" Journal 2008; edition 68: (21), on November, 1st 2008.
Optimata Ltd. announced today that it has been granted U.S. Patent 7,418,374, entitled: "Treatment protocol generation for diseases related to angiogenesis".
- In medieval musical notation, a sign or neume denoting a shake or trill.